Credit Suisse Upgrades Cboe Global Markets to Outperform, Lowers Price Target to $144
Credit Suisse analyst Gautam Sawant upgrades Cboe Global Markets (BATS:CBOE) from Neutral to Outperform and lowers the price target from $159 to $144.
Goldman Sachs’ Four Zones Within Capital Market Coverage, Gives Stock Picks
Goldman Sachs Group Inc (NYSE: GS) has outlined four themes for 2023 amid recessionary risks and rising interest rates.
Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another
The health care sector held up relatively well in a difficult year for stocks in 2022. On Wednesday, one analyst adjusted his coverage of two large cap pharmaceutical stocks heading into what could be a volatile 2023.
Etsy Has A ‘Secret Sauce’ That Should Drive Upside: Analyst
Shares of Etsy Inc (NASDAQ: ETSY) spiked in pre-market trading on Wednesday.
The New York-based company exited the pandemic stronger and has been able to hold onto the pandemic gains, according to Needham.
Benzinga’s Top Ratings Upgrades, Downgrades For January 4, 2023
Upgrades UBS upgraded the previous rating for Trane Technologies PLC (NYSE:TT) from Neutral to Buy. For the third…
UBS Upgrades Trane Technologies to Buy, Raises Price Target to $200
UBS analyst Chris Snyder upgrades Trane Technologies (NYSE:TT) from Neutral to Buy and raises the price target from $168 to $200.
Loop Capital Upgrades Burlington Stores to Hold, Raises Price Target to $200
Loop Capital analyst Laura Champine upgrades Burlington Stores (NYSE:BURL) from Sell to Hold and raises the price target from $105 to $200.
Goldman Sachs Upgrades Bank of New York Mellon to Buy, Announces $59 Price Target
Goldman Sachs analyst Alexander Blostein upgrades Bank of New York Mellon (NYSE:BK) from Neutral to Buy and announces $59 price target.
Raymond James Upgrades Maxeon Solar Technologies to Outperform, Announces $22 Price Target
Raymond James analyst Pavel Molchanov upgrades Maxeon Solar Technologies (NASDAQ:MAXN) from Market Perform to Outperform and announces $22 price target.
B of A Securities Upgrades Merck & Co to Buy, Raises Price Target to $130
B of A Securities analyst Geoff Meacham upgrades Merck & Co (NYSE:MRK) from Neutral to Buy and raises the price target from $110 to $130.